↓ Skip to main content

Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser

Overview of attention for article published in European Journal of Medical Research, November 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

facebook
1 Facebook page
googleplus
1 Google+ user

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
36 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser
Published in
European Journal of Medical Research, November 2013
DOI 10.1186/2047-783x-18-43
Pubmed ID
Authors

Said Hilton, Heike Heise, Bettina Alexandra Buhren, Holger Schrumpf, Edwin Bölke, Peter Arne Gerber

Abstract

Melasma is a common hypermelanosis of the face. The use of a classical Q-switched ruby laser (QSRL) to treat melasma is discussed controversially and is associated with frequent adverse effects, such as hyper- or hypopigmentation. Recently a fractional-mode (FRx) QSRL was developed to minimize the adverse effects of classical QSRL. The objective of this research was to evaluate the efficacy and safety of a novel FRx-QSRL in the treatment of melasma in Caucasian patients.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Slovenia 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Other 5 14%
Lecturer 3 8%
Student > Bachelor 3 8%
Researcher 3 8%
Other 8 22%
Unknown 7 19%
Readers by discipline Count As %
Medicine and Dentistry 18 50%
Nursing and Health Professions 4 11%
Biochemistry, Genetics and Molecular Biology 1 3%
Business, Management and Accounting 1 3%
Energy 1 3%
Other 1 3%
Unknown 10 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 January 2014.
All research outputs
#14,767,396
of 22,733,113 outputs
Outputs from European Journal of Medical Research
#279
of 640 outputs
Outputs of similar age
#125,488
of 212,312 outputs
Outputs of similar age from European Journal of Medical Research
#7
of 10 outputs
Altmetric has tracked 22,733,113 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 640 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 53% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,312 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.